0469-0647 : 24 Hr Astagraf 0.5 mg Extended Release Capsule


NDC0469-0647
Labeler: Astellas Pharma Us, Inc.
Product Type: Human Prescription Drug
Drug Name:  Astagraf XL
Dosage Form: Oral Capsule, Coated, Extended Release
Application #: NDA204096
Rev. Date: 


Appearance:


Shapes:  Capsule
Colors:  Yellow / Orange
Size (mm): 11
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 0469-0647-11: 5 BLISTER PACK IN 1 CARTON (0469‑0647‑11) > 10 CAPSULE, COATED, EXTENDED RELEASE IN 1 BLISTER PACK
  • 0469-0647-73: 1 BOTTLE IN 1 CARTON (0469‑0647‑73) > 30 CAPSULE, COATED, EXTENDED RELEASE IN 1 BOTTLE

Active Ingredients:

  • Tacrolimus

Dosage Strength:

  • .5 mg

Pharmaceutical Classes:

  • Calcineurin Inhibitor Immunosuppressant [EPC]
  • Calcineurin Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 0469-0677 24 Hr Astagraf 1 mg Extended Release Capsule by Astellas Pharma Us, Inc.
  • 0469-0687 24 Hr Astagraf 5 mg Extended Release Capsule by Astellas Pharma Us, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0469-0647 QR Code

< Prev: 0469-0617Next: 0469-0657 >

Related Discussions:

stopping tacrolimus
Are there any withdrawals or side effects from stopping Tacro..i had a heart tx and i'm still on Rappamune Cellcept ... 1 reply
Forskolin, Atenolol, Amlodipine, Tacrolimus, Bactrim, Humalog & Cellcept
I had a kidney transplant and am on the following medications: Tacrolimus, cellcept, amlodipine, atenolol, bactrim &... 1 reply
Tacrolimus Ointment 0 1% w/w
Tacrolimus Ointment 0 1% w/w is help full for depigmentation of skin..??...
tacrolimus assy
please send the tacrolimus assay method for research work...
Tacrolimus assay
Does anyone know how to remove the excipients from tacrolimus prior to running it on HPLC? I have found that susequent r...
tacrolimus
kidney transplant sapresant...




Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 16 July 2015.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA